作者: Deanna J. Buehrle , Ryan K. Shields , Lloyd G. Clarke , Brian A. Potoski , Cornelius J. Clancy
DOI: 10.1128/AAC.01243-16
关键词: Carbapenem resistant Pseudomonas aeruginosa 、 Treatment failure 、 Antimicrobial 、 Internal medicine 、 Bacteremia 、 Medicine 、 Retrospective cohort study 、 Young adult 、 Antibiotics 、 Pseudomonas aeruginosa
摘要: We reviewed 37 patients treated for bacteremia due to carbapenem-resistant (CR) Pseudomonas aeruginosa Although 65% of isolates were multiple-drug resistant, therapeutic options available, as all susceptible ≥1 antibiotic. A total 92% received active antimicrobial therapy, but only 57% early therapy (within 48 h). Fourteen-day mortality was 19%. Microbiologic failure occurred in 29%. The Pitt score (P = 0.046) and delayed 0.027) predictive death microbiologic failure, respectively.